Longevity MagazineA review journal of healthspan, preventative medicine and ageing
Review journal · Independent · United Kingdom
Claims about ageing, graded against the evidence for them
Eight reviews. Each grades one stated claim from A to D, gives the reasoning, and says what would change it.
8 graded reviews4 explainers4 analysis piecesLast checked 31 July 2026
What this is
Longevity Magazine is a review journal covering healthspan, preventative medicine and the biology of ageing. Each review grades one stated claim from A to D against a published methodology, describes the evidence qualitatively rather than quoting figures, and says in advance what would change the grade. It is independent, sells nothing, and gives no medical advice.
What this journal does
Claims about ageing are made in a market where the outcomes of interest take decades to measure and the products are on sale now. The result is a familiar kind of writing: a real mechanism, a real laboratory finding, and a silent step to a conclusion about human health that nobody has tested.
Every review here grades a single stated claim, states the grade at the top with the reasoning that produced it, and sets out what evidence would move it. Grades run from A to D and attach to claims rather than to substances, so the same compound can carry different grades for different assertions about it.
Evidence is described qualitatively throughout. A review will tell you that a field's trials are small, short, conducted in healthy volunteers, funded by manufacturers and not independently replicated. It will not name a study or quote a figure, for reasons set out in the editorial policy.
FigureThe grading ladder used throughout the journal. A grade attaches to a stated claim, never to a substance in general.
Where the field currently stands
Of the eight claims graded in this journal, none holds grade A on an interventional basis. One prognostic claim does. The rest sit at C or D, which means either that the human evidence is short and surrogate-based, or that the work remains preclinical.
That distribution is the most useful single fact we can offer. It is not a statement that the science is poor. Several of these fields contain excellent work. It is a statement that the claims being made in public have largely not been tested in the populations and over the durations the claims concern, and that the gap between the two is where a reader's money and risk sit.
The two claims with the strongest support concern physical activity, an intervention with no commercial sponsor and no product attached. That is worth noticing.
Raising blood NAD metabolites is well demonstrated. Changing the trajectory of human ageing is not the same claim, and it is the one the supplement market makes.
The best characterised drug in the field, and still without a trial that tests the claim being made for it. The observational signal is real and so are the reasons to distrust it.
The most convincing animal lifespan data in the field, attached to an immunosuppressant with real risks and no long human ageing trial. Both halves of that sentence matter.
Clearing senescent cells is one of the better ideas in ageing biology. Whether it can be done safely and usefully in a person is an open question with early answers only.
The single measurement most consistently associated with how long people live. That is a prognostic claim, and it should not be confused with proof that raising it causes the benefit.
Strong randomised evidence for function, strength and falls. Weaker observational evidence for mortality, resting on self-reported exposure and an odd shape at the top of the range.
Sleep changes measurably with age and poor sleep tracks poor outcomes. Which way the causal arrow points, and whether treating sleep changes anything downstream, is much less clear.
One of the few interventions here with genuine randomised human evidence. The trials are short, and when calories are matched the additional effect of the window is small.
Grade C · Intervention claim
The explainers
Method rather than substance. These apply to any health claim, in any field, from any source.
A marker moves. Nobody gets better. This is the most reliably repeated failure in preventative medicine, and the reasoning behind it is worth understanding once.
Presentation is not the opposite of clinical quality. It is now the channel through which most patients try to judge it, which is a problem worth taking seriously.